WebJul 5, 2024 · Strata Oncology Inc. is expanding the clinical trial of its Sentinel early cancer treatment with the addition of two cancer centers. ... Strata’s co-founder and CEO Dan Rhodes says the trial is a key piece of the company’s strategy to developing integrated solutions to enable smarter and earlier cancer treatment. He adds that partners like ... WebJoanna Meehan Rhodes, MD is a New York-based Northwell Health physician who specializes in Medical Oncology, Internal Medicine
Did you know?
WebJoin our CEO Dan Rhodes tomorrow January 13, at 8:05 am ET, at the JP Morgan 39th Annual Healthcare Conference as he discusses recent business activities— and… WebJul 28, 2024 · Jul 28, 2024, 10:03 ET. ANN ARBOR, Mich., July 28, 2024 /PRNewswire/ -- Strata Oncology, Inc ., a precision oncology company advancing molecular indications for cancer therapies, today announced ...
WebFeb 10, 2024 · Strata Oncology developed the IRS using treatment and outcome data matched to clinical genomic and transcriptomic profiling results that it has been collecting under the ongoing, observational Strata Trial. According to Strata CEO Dan Rhodes, the rationale behind exploring a combined gene-expression and tumor mutation burden … WebFeb 7, 2024 · "Immunotherapy has transformed cancer care and now with IRS we have the ability to predict benefit across tumor types," said Dan Rhodes, Strata Oncology co-founder and Chief Executive Officer, in the release. "We are excited to put this novel biomarker into the hands of physicians to help them ensure every patient gets their best …
WebDan Rhodes is CEO/Co-Founder at Strata Oncology Inc. See Dan Rhodes's compensation, career history, education, & memberships. WebMar 18, 2024 · Dan Rhodes has been working as a Co-Founder & Chief Executive Officer at Strata Oncology for 8 years. Strata Oncology is part of the Business Services industry, …
WebFeb 7, 2024 · Strata Oncology developed IRS using treatment data and comprehensive, ... has transformed cancer care and now with IRS we have the ability to predict benefit across tumor types,” said Dan Rhodes, Ph.D., Strata Oncology co-founder and Chief Executive Officer. “We are excited to put this novel biomarker into the hands of physicians to help ...
WebDan Rhodes is Co-Founder & Chief Executive Officer (CEO) of Strata Oncology. Discover digital health profiles with HealthTech Alpha. how many days since 9th december 2022WebDec 21, 2016 · “The problem in the market today is that for most advanced cancer patients, tumor sequencing isn’t reimbursed,” said Dan Rhodes, cofounder, CEO and president of Strata Oncology, in a recent ... high spirited crossword puzzle clueWebJul 28, 2024 · ANN ARBOR, Mich., July 28, 2024 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, … high spirited in tagalogWebPress Release: Strata Oncology : Strata Oncology Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2024 Data includes results for innovative, proprietary predictive biomarkers developed using company's molecular profiling platform ANN ARBOR, Mich., April 11, 2024 /PRNewswire/ -- Strata Oncology, Inc. ("Strata"), a … high spirited lively cheerfulWebDan Rhodes - Co-founder & CEO @ Strata Oncology - Crunchbase Person Profile Person Dan Rhodes Overview Number of Founded Organizations 1 CB Rank (Person) 476,507 … how many days since a specific dateWebDec 10, 2024 · Strata Oncology, Inc. is a precision medicine company dedicated to transforming cancer care by building a platform to systematize precision oncology across a network of health systems and pharma ... how many days since april 1WebStrata Oncology. Dan Rhodes, Founder and CEO, Strata Oncology, Inc., Ann Arbor, MI, USA, Tel: +1-734-527-1000 high spirited pte ltd